US Clinical Chemistry and Immunodiagnostics Markets Future Reviewed in New Report Published at MarketPublishers.com
06 Dec 2011 • by Natalie Aster
LONDON – Forecasts say the world clinical chemistry and immunodiagnostics markets will undergo significant changes over the nest decade. The grounds for this transformation lie in the progressive development of immunodiagnostic technologies, system engineering, automation, and IT. Convergence of new and more regulations combined with competitive expansion can also be considered as major growth contributors. This developing marketplace is poised for creating dramatic opportunities for a range of new instruments, reagent systems, and auxiliary products like specimen preparation devices, controls, calibrators, and many more.
New market research report “Future US Clinical Chemistry and Immunodiagnostics Markets: Growth Opportunities and Business Expansion Strategies” prepared by Venture Planning Group has been recently published at Market Publishers Ltd.
Report Details:
Title: Future US Clinical Chemistry and Immunodiagnostics Markets: Growth Opportunities and Business Expansion Strategies
Published: November, 2011
Pages: 600
Price: US$ 10,700
The report delves into a comprehensive analysis of the US clinical chemistry and immunodiagnostics markets, including:
- major issues pertaining to the US clinical chemistry and immunodiagnostic laboratory practice, as well as key economic, regulatory, demographic, social and technological trends;
- five- and ten-year volume and sales forecasts for over 100 clinical chemistry, TDM, endocrine, cancer, immunoprotein and abused drug assays;
- five- and ten-year volume forecasts for serum, whole blood, plasma, CFS, urine and other specimens;
- five- and ten-year reagent and instrument sales forecasts;
- review of current instrumentation technologies, and a feature comparison of 50 high, medium-, and low-volume/POC analyzers;
- sales and market shares of leading reagent and instrument suppliers;
- review of current and emerging technologies and their potential market applications;
- product development opportunities for clinical chemistry and immunodiagnostic instruments and consumables;
- profiles of 25 current and emerging suppliers;
- market penetration strategies, entry barriers and risks.
Reports Contents:
Introduction
Worldwide Market and Technology Overview
A. Major Routine Chemistry Tests
1. Albumin
2. Alkaline Phosphatase
3. ALT/SGPT
4. Ammonia
5. Amylase
6. AST/SGOT
7. Bilirubin
8. Blood Gases
9. Blood Urea Nitrogen (BUN)
10. Calcium
11. Cholesterol
12. Cholinesterase
13. Creatinine
14. Electrolytes
a. Carbon Dioxide/Bicarbonate
b. Chloride
c. Potassium
d. Sodium
15. Fructosamine
16. Gamma-Glutamyl Transpeptidase (GGT)
17. Glucose
18. High Density Lipoprotein (HDL)
19. Iron
20. Lactate Dehydrogenase (LDH)
21. Magnesium
22. Phosphorus
23. Protein
24. Triglycerides
25. Uric Acid
26. Troponin
B. Therapeutic Drug Monitoring (TDM)
1. Overview
2. Carbamazepine
3. Digoxin
4. Gentamicin
5. Lidocaine
6. Lithium
7. Phenytoin/Dilantin
8. Procainamide
9. Quinidine
10. Theophylline
11. Valproic Acid
C. Endocrine Function Tests
1. Cortisol
2. Follicle-Stimulating Hormone (FSH)
3. Gastrin
4. Human Chorionic Gonadotropin (HCG)
5. LH
6. Prolactin
7. T3
8. T3 Uptake
9. Free T3
10. Thyroxine (T4)
11. Free T4
12. TBG
13. TSH
D. Tumor Markers And Special Chemistry Tests
1. Alpha-Fetoprotein (AFP)
2. Carcinoembrionic Antigen (CEA)
3. Ferritin
4. Follate/Folic Acid
5. Occult Blood
6. Prostatic Acid Phosphatase (PAP)
7. Prostate-Specific Antigen (PSA)
8. Vitamin B-12
E. Immunoprotein Tests
1. Complement
a. C3
b. C4
2. CRP
3. Immunoglobulins (IgA, IgE, IgG, IgM)
4. Protein Electrophoresis
F. Drugs of Abuse
1. Overview
2. Test Methodologies
3. Amphetamines
4. Barbiturates
5. Benzodiazepines
6. Cannabinoids/Marijuana
7. Cocaine
8. Lysergic Acid Diethylamide (LSD)
9. Methadone
10. Methaqualone
11. Opiates
12. Phencyclidine
G. Instrumentation Review
Abaxis Piccolo
Abaxis Piccolo Xpress
Abbott AxSYM
Abbott Architect c4000
Abbott Architect i2000 Series
Abbott Architect ci8200 System
Abbott i-STAT
Alfa Wassermann ACE Alera
AMS Liasys
Awareness Technologies ChemWell
Awareness Technology STAT FAX 4500
Beckman Coulter Unicel Series
Beckman Coulter Access
Binding Site ESP600
bioMerieux Mini Vidas
Carolina Chemistries BioLis 24i
DiaSorin Liaison
Grifols Triturus
Horiba ABX Pentra 400
Inverness DS2
J&J DT System
J&J Vitros ECi/ECiO
J&J Vitros 3600
J&J Vitros 5600
Medica EasyRA
Nova Biomedical Critical Care Xpress
Olympus AU480
Olympus AU5400
Olympus AU53000i
Olympus AU2700
Polymedco Poly-Chem
Polymedco Spotchem EZ
Randox RX Daytona
Randox RX Imola
Roche Modular Analytics
Roche Cobas Integra 400
Roche Cobas Integra 400 Plus
Roche Elecsys
Roche Cobas c311
Roche Cardiac 200
Siemens ADVIA Centaur
Siemens Dimension
Siemens Dimension RxL Max
Siemens Dimension Vista 500
Siemens Immulite
Siemens Stratus
Tosoh AIA-Series
Vital Diagnostics ATAC 8000
Vital Diagnostics Envoy 500
H. Major In Vitro Diagnostic Technologies
And Their Potential Applications
1. Monoclonal and Polyclonal Antibodies
2. Immunoassays
a. Technological Principle
b. Radioimmunoassays (RIA)
c. Enzyme Immunoassays (EIA)
Overview
ELISA
EMIT
Immunofiltration
Dot Immunobinding Assays
Capillary Immunoassays
Particle-Membrane Capture Immunoassays
Enzyme Amplification
CEDIA
Electrochemical Immunoassays
d. Fluorescent Immunoassays
Fluorescence Polarization
Time-Resolved Pulse Fluorescence
e. Luminescence
Chemiluminescence
Bioluminescence
f. Latex Agglutination
g. Immunoprecipitation
h. Affinity Chromatography Immunoassays
i. Liposome Flow-Injection Immunoassays
3. IT and Automation
4. Dry Chemistry
5. Biosensors
6. Robotics
7. Chemometrics
8. Molecular Diagnostics
a. Sample Preparation
b. Hybridization
c. Separation
d. Detection/Measurement
Test Formats
a. Filter Hybridization
b. Southern Blot
c. Northern Blot
d. In Situ Hybridization
e. Others
Labeling Techniques
Amplification Methods
Polymerase Chain Reaction
Temperature Cyclers
PCR Variations
Immuno-PCR
QC-PCR.
DAP-PCR
Strand Displacement Activation
TMA
Ligase Chain Reaction
Branched DNA
Hybridization Protection Assay
Nucleic-Acid Sequence-Based Amplification
Self-Sustained Sequence Replicase
Others
Ampliprobe
CAR
CAS
CPT
Dendritic Polymer Technology
ISO-CR
LAT
Probe Networks
RAMP
Repair Chain Reaction
Rolling Circles
Sequence Independent Gene Amplification
Sequence Initiation Reaction
SISPA
Solid Phase Amplification
Detection Technologies
a. Radioactive Methods
Overview
Major Isotopes
P-32
S-35
H-3
I-125
b. Non-Isotopic Methods
Enzymatic Labels
Chemical Labeling
Indirect Chemical Labeling
Direct Chemical Labeling
Fluorescence
Chemiluminescence
Electrical Conductivity
Instrumentation Review
a. Abbott LCx
b. Beckman Coulter/Biomek FK
c. Becton Dickinson SDA
d. Bio-Rad GeneScope
e. Gen-Probe Tigris
f. Roche Cobas Amplicor
g. Tecan LS Series
Biochips: Genosensors, Microarrays, and Labs-on-the-chip
Liquid Transportation and Mixing
Separation
Reaction
Detection
Worldwide Market Overview
1. Business Environment
2. Market Structure
3. Market Size and Growth
U.S.A.
A. Executive Summary
B. Business Environment
1. Health Care Expenditures
2. Cost Consciousness
3. Industry Consolidation
4. Managed Care
5. Hospitals
6. Admissions
7. Length of Stay
8. Industry Diversification
9. Physician Demographics
10. Population Aging
a. Chronic Illness
b. Disease Incidence
c. Susceptibility to Iatrogenesis
d. Multiple Illness Cases
11. Laboratory Regulations
C. Market Structure
1. Centralized Testing
a. Hospitals
b. Commercial/Private Laboratories
2. Decentralized Testing
a. Physician Offices/Group Practices
b. Point-of-Care Testing
c. Home/Self Testing
d. Other Decentralized Testing Locations
D. Market Size, Growth and Major Suppliers' Instrument and Reagent Sales, and Market Shares
Major Product Development Opportunities
Design Criteria for Decentralized Testing Products
Alternative Market Penetration Strategies
A. Internal Development
B. Collaborative Arrangements
C. University Contracts
D. Distribution Strategies for Decentralized
Testing Markets
1. Marketing Approaches
2. Product Complexity
3. Customer Preference
4. Established Suppliers
5. Emerging Suppliers
6. Major Types of Distributors
7. Market Segmentation
Potential Market Entry Barriers and Risks
A. Market Maturity
B. Cost Containment
C. Competition
D. Technological Edge and Limitations
E. Patent Protection
F. Regulatory Constraints
G. Decentralized Testing Market Challenges
Competitive Assessments
Abbott Laboratories
AdnaGen
Ambrilia
AMDL
Beckman Coulter
Biomedical Diagnostics
BioMerieux
Bio-Rad
Canag Diagnostics
Dako
DiaSorin
Eiken
Fujirebio
Instrumentation Laboratory
J&J
Kyowa Medex
Matritech
Roche
Siemens
Sysmex
Thermo Fisher
Trinity Biotech
Tosoh
Wako
Wallac
List of Tables
More new market research reports by the publisher can be found at Venture Planning Group page.
CONTACTS
The Market Publishers, Ltd.
Tanya Rezler
Tel: +44 208 144 6009
Fax: +44 207 900 3970
Analytics & News
